Retigabine to be discontinued in June
We have received a reminder notice from GSK that retigabine (Trobalt®/Potiga®) will be removed from clinical use at the end of June. Please discuss the issues with any patient who remains on the medication and how they need to be transitioned to other drugs as clinically indicated. Details here.
Subscribe to the ILAE Newsletter
To subscribe, please provide your email address.